One Global Service Provider Limited shareholders approved the audited financial statements for FY26, marking a year of significant growth in revenue and profitability. The 34th Annual General Meeting, held on September 29, 2026, also sanctioned key strategic moves including a preferential issue to acquire stakes in two diagnostic entities.

The meeting, conducted via Video Conferencing, saw members adopt the standalone audited financials alongside reports from the Board of Directors and Statutory Auditors. A dividend on equity shares for FY26 was also declared. Additionally, shareholders ratified the re-appointment of Sanjay Upadhyay as Managing Director and approved the appointment of SDPM & Co., Chartered Accountants, as Statutory Auditors for a second five-year term.

Strategic Acquisitions and Capital Structure

A central focus of the AGM was the approval of special resolutions facilitating corporate expansion. Members authorized an increase in authorized share capital and the issuance of 7,06,068 equity shares on a preferential basis. This non-cash consideration is earmarked for acquiring a 51% equity stake each in Matrix Labs Diagnocare Private Limited and Matrix Labs Private Limited.

These acquisitions are part of the company’s strategy to strengthen its presence in the healthcare, diagnostics, and In-Vitro Diagnostics (IVD) sector. The company also highlighted the successful amalgamation of Plus Care Internationals Private Limited, which has broadened its capabilities in the healthcare ecosystem.

Financial Performance Highlights

The Chairman reported robust financial metrics for FY26 compared to the previous year. Total revenue nearly tripled, while Profit After Tax (PAT) more than tripled, reflecting strong operational leverage.

Note: Percentages calculated based on source figures.

What the Numbers Show

The divergence between revenue growth (+237.4%) and PAT growth (+276.4%) indicates significant margin expansion during FY26. While net worth nearly doubled, the Return on Equity jumped from 25.75% to 49.21%, suggesting that the company is generating substantially higher returns on its capital base, likely driven by the operational synergies from the recent amalgamation and improved asset utilization.

Other Key Resolutions

Beyond financial adoption and acquisitions, the AGM addressed several governance and operational matters:

• Approval for overall borrowing limits under Section 180(1)(c) of the Companies Act, 2013.
• Authorization to create mortgages or charges on assets under Section 180(1)(a).
• Approval for loans, inter-corporate deposits, and guarantees exceeding prescribed limits under Section 186.
• Ratification of remuneration payable to Cost Auditors J.H. Survase & Co.
• Approval for material related-party transactions with Lifenity Health Limited.

The voting results for these resolutions were conducted via remote e-voting and e-voting during the meeting, with detailed outcomes to be submitted separately as per SEBI Listing Regulations.

One Global Service Provider revised the pricing and number of shares for its preferential equity issuance to acquire controlling stakes in Matrix Labs Diagnocare Private Limited (MLDPL) and Matrix Labs Private Limited (MLPL). The board approved the changes on September 18, 2026, following queries from BSE Limited during the in-principle approval process. The revision ensures compliance with SEBI ICDR Regulations while keeping the total acquisition cost fixed.

The company will now issue 7,06,068 fully paid-up equity shares with a face value of ₹10 each, down from the initially proposed 7,15,040 shares. The transaction involves acquiring a 51% stake in both entities. The consideration is payable entirely through the issuance of these shares, meaning no cash outflow is required from One Global Service Provider for the purchase.

Revised Pricing Structure

The Board amended the Share Purchase Agreements (SPAs) to reflect new issue prices determined under Chapter V of the SEBI (ICDR) Regulations. The aggregate non-cash consideration for both deals remains unchanged from the initial agreements dated September 3, 2026. The revised prices are ₹560.13 per share for MLDPL and ₹558.99 per share for MLPL, up from the earlier price of ₹553 per share.

The shares for MLDPL are allotted to Mr. Suresh (5,93,998 shares) and Ms. Nithya S (48,320 shares). The shares for MLPL are allotted to Mr. Suresh (63,750 shares). The premium per share is ₹550.13 for MLDPL and ₹548.99 for MLPL.

Strategic Expansion in Healthcare

The acquisitions aim to strengthen One Global Service Provider’s presence in the diagnostic, pathology, and allied healthcare services sector. The addendums confirm that no special rights, such as director appointments or restrictions on capital structure changes, are granted to the sellers. The company stated that these amendments do not adversely impact its business or operations.

What the Numbers Show

The total value of the combined acquisitions stands at ₹39,54,17,120. By utilizing a non-cash consideration model, One Global Service Provider preserves its cash reserves while expanding its asset base. The increase in issue price from ₹553 to approximately ₹560 resulted in a reduction of 8,972 equity shares to be issued by the company. This adjustment was driven by a revised share exchange ratio certificate dated September 17, 2026, which updated the fair value of One Global Service Provider’s equity shares to ₹558.93, based on the 10-trading day volume-weighted average price on BSE.